PDF(Pubmed)
Abstract：
UNASSIGNED: Gross total resection (GTR) of intracranial meningiomas is curative in most cases. However, perioperative blood transfusions may be necessary for complex skull bases and/or high-grade meningiomas. Guidelines for blood transfusions during intracranial meningioma surgery remain unclear. This scoping review aims to delineate the main characteristics of patients who underwent intracranial meningioma surgery, the prevalence of the selected patients who required blood transfusions, and common causes for transfusion.
UNASSIGNED: A scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Extension for Scoping Reviews guidelines to include studies reporting eligibility, protocols, and potential complications related to blood transfusion within the perioperative management of intracranial meningiomas.
UNASSIGNED: A total of 33 articles encompassing 3009 meningioma patients were included in the study. The most common symptom was headache (18%), and the most frequent type of meningioma was World Health Organization grade-1 meningothelial (50.4%). The lateral supraorbital approach was the most common surgical corridor (59.1%) in skull base meningiomas, and most patients underwent GTR (69%). Blood transfusion was required for 20% of patients, with a mean estimated intraoperative blood loss of 703 mL (ranging from 200 mL to 2000 mL). The main indications for blood transfusion in meningioma surgery were intraoperative blood loss (86%) and preoperative anemia (7.3%).
UNASSIGNED: This scoping found that 20% of the included patients required blood transfusion. It also points out that several factors could influence the necessity for a transfusion, encompassing surgical blood loss, pre-existing anemia, and the surgery\'s length. This scoping review may provide surgeons with a potential guide to inform their decision-making process regarding blood transfusions during meningioma surgeries.
UNASSIGNED: A scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Extension for Scoping Reviews guidelines to include studies reporting eligibility, protocols, and potential complications related to blood transfusion within the perioperative management of intracranial meningiomas.
UNASSIGNED: A total of 33 articles encompassing 3009 meningioma patients were included in the study. The most common symptom was headache (18%), and the most frequent type of meningioma was World Health Organization grade-1 meningothelial (50.4%). The lateral supraorbital approach was the most common surgical corridor (59.1%) in skull base meningiomas, and most patients underwent GTR (69%). Blood transfusion was required for 20% of patients, with a mean estimated intraoperative blood loss of 703 mL (ranging from 200 mL to 2000 mL). The main indications for blood transfusion in meningioma surgery were intraoperative blood loss (86%) and preoperative anemia (7.3%).
UNASSIGNED: This scoping found that 20% of the included patients required blood transfusion. It also points out that several factors could influence the necessity for a transfusion, encompassing surgical blood loss, pre-existing anemia, and the surgery\'s length. This scoping review may provide surgeons with a potential guide to inform their decision-making process regarding blood transfusions during meningioma surgeries.
摘要：
■颅内脑膜瘤的大体全切除（GTR）在大多数情况下是治愈的。然而,对于复杂的颅底和/或高级别脑膜瘤,围手术期可能需要输血.颅内脑膜瘤手术期间的输血指南仍不清楚。这项范围审查旨在描述接受颅内脑膜瘤手术的患者的主要特征，需要输血的选定患者的患病率，和输血的常见原因。
根据系统审查的首选报告项目和范围审查的荟萃分析扩展指南进行范围审查，以包括报告合格性的研究。协议,以及颅内脑膜瘤围手术期处理中与输血相关的潜在并发症。
■本研究共纳入33篇文章，包括3009例脑膜瘤患者。最常见的症状是头痛（18%）。最常见的脑膜瘤类型是世界卫生组织1级脑膜上皮(50.4%)。眶上外侧入路是颅底脑膜瘤最常见的手术走廊（59.1％），大多数患者接受GTR（69％）。20%的病人需要输血,平均估计术中失血量为703mL（200mL至2000mL）。脑膜瘤手术输血的主要指征为术中失血(86%)和术前贫血(7.3%)。
■这项范围研究发现，纳入的患者中有20％需要输血。它还指出，有几个因素可能影响输血的必要性，包括手术失血，预先存在的贫血，和手术的长度。这种范围审查可以为外科医生提供潜在的指导，以告知他们在脑膜瘤手术期间输血的决策过程。
根据系统审查的首选报告项目和范围审查的荟萃分析扩展指南进行范围审查，以包括报告合格性的研究。协议,以及颅内脑膜瘤围手术期处理中与输血相关的潜在并发症。
■本研究共纳入33篇文章，包括3009例脑膜瘤患者。最常见的症状是头痛（18%）。最常见的脑膜瘤类型是世界卫生组织1级脑膜上皮(50.4%)。眶上外侧入路是颅底脑膜瘤最常见的手术走廊（59.1％），大多数患者接受GTR（69％）。20%的病人需要输血,平均估计术中失血量为703mL（200mL至2000mL）。脑膜瘤手术输血的主要指征为术中失血(86%)和术前贫血(7.3%)。
■这项范围研究发现，纳入的患者中有20％需要输血。它还指出，有几个因素可能影响输血的必要性，包括手术失血，预先存在的贫血，和手术的长度。这种范围审查可以为外科医生提供潜在的指导，以告知他们在脑膜瘤手术期间输血的决策过程。
